CS185669B2 - Method of producing new derivatives of phenoxypropylamine - Google Patents

Method of producing new derivatives of phenoxypropylamine

Info

Publication number
CS185669B2
CS185669B2 CS7400008838A CS883874A CS185669B2 CS 185669 B2 CS185669 B2 CS 185669B2 CS 7400008838 A CS7400008838 A CS 7400008838A CS 883874 A CS883874 A CS 883874A CS 185669 B2 CS185669 B2 CS 185669B2
Authority
CS
Czechoslovakia
Prior art keywords
phenoxypropylamine
producing new
new derivatives
derivatives
producing
Prior art date
Application number
CS7400008838A
Other languages
Czech (cs)
English (en)
Inventor
Gerhard Zoelss
Heribert Pittner
Stormann-Menninger-Lerchenthal
Original Assignee
Chemie Linz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemie Linz Ag filed Critical Chemie Linz Ag
Publication of CS185669B2 publication Critical patent/CS185669B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/38—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by doubly-bound oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CS7400008838A 1973-12-20 1974-12-20 Method of producing new derivatives of phenoxypropylamine CS185669B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT1066673A AT334385B (de) 1973-12-20 1973-12-20 Verfahren zur herstellung von neuen phenoxypropylaminderivaten und deren salzen

Publications (1)

Publication Number Publication Date
CS185669B2 true CS185669B2 (en) 1978-10-31

Family

ID=3623884

Family Applications (1)

Application Number Title Priority Date Filing Date
CS7400008838A CS185669B2 (en) 1973-12-20 1974-12-20 Method of producing new derivatives of phenoxypropylamine

Country Status (19)

Country Link
US (1) US4034009A (fr)
JP (2) JPS5412461B2 (fr)
AT (1) AT334385B (fr)
BE (1) BE823411A (fr)
CA (1) CA1001626A (fr)
CH (1) CH612417A5 (fr)
CS (1) CS185669B2 (fr)
DD (1) DD118421A1 (fr)
ES (1) ES433145A1 (fr)
FR (1) FR2255058B1 (fr)
GB (1) GB1441359A (fr)
IE (1) IE40310B1 (fr)
IL (1) IL46259A (fr)
LU (2) LU71514A1 (fr)
PL (1) PL94095B1 (fr)
RO (1) RO69147A (fr)
SU (1) SU547174A3 (fr)
YU (1) YU36492B (fr)
ZA (1) ZA748067B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177280A (en) * 1978-07-03 1979-12-04 Syntex (U.S.A.) Inc. Bicyclo[3.1.0]hexyl-substituted carbonylaminophenoxy cardiovascular agents
JPS5757231U (fr) * 1980-09-19 1982-04-03
US4470965A (en) * 1982-10-27 1984-09-11 Usv Pharmaceutical Corporation Celiprolol for the treatment of glaucoma
DE3410380A1 (de) * 1984-03-21 1985-10-10 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München S(-)-celiprolol, dessen pharmazeutisch vertraegliche salze, verfahren zu dessen herstellung, verwendung in der therapie und pharmazeutische zubereitungen
DE3544172A1 (de) * 1985-12-13 1987-06-19 Lentia Gmbh Neue kristalline salze von aryloxy-propanolaminen, verfahren zu ihrer herstellung und ihre verwendung
DE3636209A1 (de) * 1986-10-24 1988-04-28 Lentia Gmbh Verfahren zur herstellung eines bindemittelfreien tablettierfaehigen celiprololhydrochlorid-granulates
BR0313593A (pt) 2002-08-19 2005-07-12 Pfizer Prod Inc Terapia de combinação para doenças hiperproliferativas
CN1812983A (zh) * 2003-05-30 2006-08-02 兰贝克赛实验室有限公司 取代的吡咯衍生物及其作为hmg－co抑制剂的用途
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
WO2007029155A2 (fr) * 2005-09-05 2007-03-15 Ranbaxy Laboratories Limited Procede de preparation ameliore d'une base de celiprolol pure
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
SG166829A1 (en) * 2005-11-08 2010-12-29 Ranbaxy Lab Ltd Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
AR059838A1 (es) * 2006-03-14 2008-04-30 Ranbaxy Lab Ltd Formulaciones para dosis estabilizantes de estatina
CL2007002044A1 (es) * 2006-07-14 2008-06-13 Ranbaxy Lab Ltd Polimorfo cristalino de la sal hemicalcica del acido (3r,5r)-7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroximetilfenilamino)carbonil]-pirrol-1-il]-3,5-dihidroxiheptanoico; composicion farmaceutica; y uso para el tratamiento de la diabetes, enf
ATE547394T1 (de) 2006-12-01 2012-03-15 Bristol Myers Squibb Co N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen
WO2008151257A2 (fr) 2007-06-04 2008-12-11 Synergy Pharmaceuticals Inc. Agonistes de guanylase cyclase utiles pour le traitement de troubles gastro-intestinaux, d'inflammation, de cancer et d'autres troubles
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US8987262B2 (en) 2007-10-19 2015-03-24 Universite de Bordeaux Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas
EP2050441A1 (fr) 2007-10-19 2009-04-22 Université Victor Segalen Bordeaux 2 Utilisation de bêtabloquants pour la fabrication d'un médicament pour le traitement d'hémangiomes
WO2009149279A2 (fr) 2008-06-04 2009-12-10 Synergy Pharmaceuticals Inc. Agonistes de guanylate cyclase utile dans le traitement de troubles gastro-intestinaux, d'une inflammation, d'un cancer et d'autres troubles
CA2730603C (fr) 2008-07-16 2019-09-24 Synergy Pharmaceuticals Inc. Agonistes de la guanylate cyclase utiles dans le traitement des affections gastro-intestinales, de l'inflammation gastro-intestinale, du cancer gastro-intestinal et d'autres affections
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
EP2970384A1 (fr) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonistes de la guanylate cyclase et leurs utilisations
WO2014151200A2 (fr) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions utiles pour le traitement de troubles gastro-intestinaux
CA2909442A1 (fr) 2013-04-17 2014-10-23 Pfizer Inc. Derives de n-piperidin-3-ylbenzamide dans le traitement des maladies cardiovasculaires
AU2014274812B2 (en) 2013-06-05 2018-09-27 Bausch Health Ireland Limited Ultra-pure agonists of guanylate cyclase C, method of making and using same
WO2016055901A1 (fr) 2014-10-08 2016-04-14 Pfizer Inc. Composés d'amide substitué
HUE069590T2 (hu) 2019-01-18 2025-03-28 Astrazeneca Ab PCSK9-gátló 6'-[[(1s,3s)-3-[[5-(difluormetoxi)-2-pirimidinil]amino]ciklopentil]amino][1(2h ),3'-bipiridin]-2-on és alkalmazására szolgáló eljárások

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1214012A (en) * 1967-12-21 1970-11-25 Allen & Hanburys Ltd Phenylethanolamines
FR8183M (fr) * 1967-12-22 1970-09-07
US3935259A (en) * 1970-01-08 1976-01-27 Ciba-Geigy Corporation New amines and processes for their manufacture
SE354851B (fr) * 1970-02-18 1973-03-26 Haessle Ab
NL7115581A (fr) * 1970-11-13 1972-05-16 Dresden Arzneimittel
GB1396322A (en) * 1971-06-15 1975-06-04 Ici Ltd Alkanolamine derivatives
GB1393675A (en) 1971-06-16 1975-05-07 Ici Ltd Alkanolamine derivatives
SE386892B (sv) * 1972-07-06 1976-08-23 Haessle Ab Forfarande for framstellning av oxaminoforeningar
GB1455116A (en) * 1972-12-15 1976-11-10 Ici Ltd Pharmaceutical compositions
AT330150B (de) * 1973-02-28 1976-06-10 Boehringer Sohn Ingelheim Verfahren zur herstellung von neuen 1-phenoxy-2-hydroxy -3- propargylaminopropanen und von deren saureadditionssalzen
GB1460593A (en) * 1973-06-22 1977-01-06 Ici Ltd Ethanolamine derivatives
FI65987C (fi) * 1973-12-12 1984-08-10 Ici Ltd Foerfarande foer framstaellning av nya terapeutiskt anvaendbara alkanolaminderivat
AT334386B (de) * 1973-12-21 1976-01-10 Chemie Linz Ag Verfahren zur herstellung von neuen phenoxypropylaminderivaten und deren salzen

Also Published As

Publication number Publication date
AT334385B (de) 1976-01-10
ZA748067B (en) 1976-01-28
YU327774A (en) 1982-02-25
CA1001626A (en) 1976-12-14
FR2255058B1 (fr) 1978-07-28
IL46259A (en) 1978-04-30
LU88296I2 (fr) 1994-05-04
IL46259A0 (en) 1975-03-13
JPS5412461B2 (fr) 1979-05-23
IE40310L (en) 1975-06-20
ATA1066673A (de) 1976-05-15
US4034009A (en) 1977-07-05
ES433145A1 (es) 1976-11-16
FR2255058A1 (fr) 1975-07-18
SU547174A3 (ru) 1977-02-15
GB1441359A (en) 1976-06-30
DD118421A1 (fr) 1976-03-05
JPS53149947A (en) 1978-12-27
RO69147A (fr) 1981-07-30
IE40310B1 (en) 1979-04-25
LU71514A1 (fr) 1975-08-20
JPS5549071B2 (fr) 1980-12-10
CH612417A5 (fr) 1979-07-31
AU7653874A (en) 1976-06-17
PL94095B1 (fr) 1977-07-30
JPS5095246A (fr) 1975-07-29
YU36492B (en) 1984-02-29
BE823411A (fr) 1975-06-16

Similar Documents

Publication Publication Date Title
CS185669B2 (en) Method of producing new derivatives of phenoxypropylamine
CS185654B2 (en) Method of producing derivatives of 1,1,-diaminoethylene
CS181264B2 (en) Method for production of alpha-amino-alpha-/ureidophenyl/acetamidocephalosporins
CS189661B2 (en) Method of producing derivatives of tetrahydroacridine
YU338574A (en) Process for obtaining new derivatives of pregnane-21-acid
CS191225B2 (en) Method of production of new n-phenylpyrrols
CS183634B2 (en) Method for producing novel derivatives of 2-aminomethyl-4,6-dihalogenephenol
CS184347B2 (en) Method for producing derivatives of 1-phenoxy-2-hydroxy-3-aminopropane
CS179438B2 (en) Method of producing new 2-phenylamino-2-imidazoles
CS183775B2 (en) Method of producing new derivatives of diazine
CS188920B2 (en) Method of producing novel aminobenzylamines
CS178930B2 (en) Method for production of new lactones of d-homosteroids
CS180640B2 (en) Method of producing new substituted derivatives of nitrobenzofenone
CS188189B2 (en) Method of producing cyanopyridines
CS184838B2 (en) Method of producing derivatives of 1-phenoxy-3-amino-2-propanol
YU214174A (en) Process for obtaining new derivatives of amino-pyrrol
CS180646B2 (en) Method of producing new substituted derivatives of amides of alfa-aminooxycarboxylic acids
CS175748B1 (en) Method of alfa-6-deoxytetracycline production
CS194248B2 (en) Method of producing novel derivatives of 1-phthalazone
BG23751A3 (en) Method of obtaining benzofuran derivatives
CS187314B2 (en) Method of producing acetophenone derivatives
CS194213B2 (en) Method of producing novel derivatives of 1-phthalazone
CS181278B2 (en) Method of producing cephalosporane acid derivatives
CS181691B2 (en) Method of producing new derivatives of phenoxypropylamine
CS182825B2 (en) Method for the production of novel derivatives of phenoxypropylamine and their salts